Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula

被引:31
作者
Abassi, ZA
Brodsky, S
Karram, T
Dobkin, I
Winaver, J
Hoffman, A
机构
[1] Rambam Med Ctr, Dept Vasc Surg, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Physiol & Biophys, IL-31096 Haifa, Israel
关键词
anti-hypertensive/diuretic agents; heart failure; natriuretic peptide; renin-angiotensin system; vasoactive agents; blood pressure;
D O I
10.1016/S0008-6363(01)00245-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Surgical closure of a large arteriovenous (A-V) fistula in patients and animals is associated with prompt diuresis and natriuresis. However, the mechanisms underlying these changes remained largely unknown. Methods: The present study evaluated the hormonal balance between major antinatriuretic systems (plasma renin activity, PRA, and arginine vasopressin, AVP) and natriuretic systems (atrial natriuretic peptide, ANP, and renal nitric oxide, NO) in Wistar rats with an A-V fistula (1.2 mm O.D., side to side) between the abdominal aorta and inferior vena cava. Results: The placement of an A-V fistula caused progressive sodium retention (UNaV decreased from 1500 to 100 mu equiv./day), a significant drop in mean arterial blood pressure (MAP) from 127 +/-3 to 75 +/-2 mmHg (P <0.01), and a significant increase in ANP (from 94 +/- 12 to 389 +/- 135 pg/ml, P <0.05), PRA (from 22.1 +/-2.0 to 47 +/- 14 ng angiotensin I [Ang I]/ml/h, P <0.05), AVP (from 14.2 +/-3.6 to 37.7 +/-9.6 pg/ml, P <0.05), norepinephrine (from 184.2 +/- 40.5 to 1112.6 +/- 293.2 pg/ml, P<0.05) and epinephrine (from 667.5<plus/minus>175.9 to 2049.8 +/- 496.9 pg/ml, P <0.05). Furthermore, these changes were associated with a 3-fold increase in the renal medullary immunoreactive levels of endothelial NO synthase (eNOS), an endogenous vasodilator that plays an important role in the regulation of medullary blood flow. After 6 days, rats with A-V fistula and maximal sodium retention underwent surgical closure of the A-V fistula. The A-V fistula closure was associated with dramatic natriuresis (UNaV=2563 +/- 78 and 1918 +/- 246 mu Eq/day on days 3 and 6 following the closure, respectively) and restoration of MAP to normal levels (111 +/-6 mmHg); PRA decreased to 29 +/-5 ng Ang I/ml/h, AVP to 20.3 +/-7.1 pg/ml, and medullary eNOS declined to basal levels, whereas plasma ANP concentrations remained elevated (380 +/- 90 pg/ml) after 3 days and returned to normal (92 +/- 12 pg/ml) on day 6. Conclusions: These results demonstrate that the creation of A-V fistula is associated with activation of both natriuretic and antinatriuretic systems. Closure of A-V fistula is characterized by shifting the balance in favor of the natriuretic substances. Moreover, the observed alterations in medullary eNOS following the creation and closure of A-V fistula suggest that this system, an important determinant of medullary blood flow, may contribute significantly to the regulation of sodium excretion in this model. (C) 2001 Elsevier Science BY. All rights reserved.
引用
收藏
页码:567 / 576
页数:10
相关论文
共 48 条
[1]   Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide [J].
Abassi, Z ;
Gurbanov, K ;
Rubinstein, I ;
Better, OS ;
Hoffman, A ;
Winaver, J .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (04) :F766-F774
[2]   EFFECT OF CONVERTING-ENZYME INHIBITION ON RENAL RESPONSE TO ANF IN RATS WITH EXPERIMENTAL HEART-FAILURE [J].
ABASSI, Z ;
HARAMATI, A ;
HOFFMAN, A ;
BURNETT, JC ;
WINAVER, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (01) :R84-R89
[3]  
ABASSI ZA, 1994, J PHARMACOL EXP THER, V268, P224
[4]   RENAL HEMODYNAMIC FACTORS IN CONGESTIVE HEART FAILURE [J].
BARGER, AC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1966, 139 (A2) :276-&
[5]  
BROD J, 1954, ACTA MED SCAND, V148, P273
[6]   Effects of eprosartan on renal function and cardiac hypertrophy in rats with experimental heart failure [J].
Brodsky, S ;
Gurbanov, K ;
Abassi, Z ;
Hoffman, A ;
Ruffolo, RR ;
Feuerstein, GZ ;
Winaver, J .
HYPERTENSION, 1998, 32 (04) :746-752
[7]   ATRIAL-NATRIURETIC-PEPTIDE ELEVATION IN CONGESTIVE-HEART-FAILURE IN THE HUMAN [J].
BURNETT, JC ;
KAO, PC ;
HU, DC ;
HESER, DW ;
HEUBLEIN, D ;
GRANGER, JP ;
OPGENORTH, TJ ;
REEDER, GS .
SCIENCE, 1986, 231 (4742) :1145-1147
[8]   KIDNEY IN HEART-FAILURE [J].
CANNON, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (01) :26-32
[9]   ATRIAL-NATRIURETIC-FACTOR IN NORMAL SUBJECTS AND HEART-FAILURE PATIENTS - PLASMA-LEVELS AND RENAL, HORMONAL, AND HEMODYNAMIC-RESPONSES TO PEPTIDE INFUSION [J].
CODY, RJ ;
ATLAS, SA ;
LARAGH, JH ;
KUBO, SH ;
COVIT, AB ;
RYMAN, KS ;
SHAKNOVICH, A ;
PONDOLFINO, K ;
CLARK, M ;
CAMARGO, MJF ;
SCARBOROUGH, RM ;
LEWICKI, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1362-1374
[10]   SODIUM AND WATER-BALANCE IN CHRONIC CONGESTIVE-HEART-FAILURE [J].
CODY, RJ ;
COVIT, AB ;
SCHAER, GL ;
LARAGH, JH ;
SEALEY, JE ;
FELDSCHUH, J .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (05) :1441-1452